Debiopharm Group Investor
Debiopharm Group is a biopharmaceutical development specialist that in-licenses promising biologics and small molecule drug candidates. They develop their products for global registration and maximum commercial potential for out-licensing to pharmaceutical partners for sales and marketing.
Industry:
BioPharma AI
Technology:
Biomarker Discovery & Validation
Number Of Exists:
5
Investor Type:
Private Equity Funds
Headquarters:
Lausanne,Vaud,Switzerland,Europe
Funding Status:
private
Employee Number:
251-500
Founded Date:
1979-01-01